NCT05023850

Brief Summary

Major spinal surgery causes greater pain in the postoperative 24 hours. Patients with severe pain may have prolonged hospital stays and delay in mobilization. In addition, chronic pain may be seen in these patients due to ineffectively managed acute postoperative pain. Therefore, optimizing acute postoperative analgesia is a priority in patients undergoing major spinal surgery. Recently, ultrasound-guided interfascial plane blocks such as thoracolumbar interfascial plane block (TLIPB)and the erector spinae plane block (ESPB) have been described in spinal surgery. Both blocks clinically seem to be safe and easily performed. The aims of this study are to compare the quality of recovery scores, overall morbidity and postoperative analgesia after major spinal surgery in patients receiving either TLIPB or ESPB.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 27, 2021

Completed
14 days until next milestone

Study Start

First participant enrolled

September 10, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2022

Completed
Last Updated

May 24, 2022

Status Verified

September 1, 2021

Enrollment Period

9 months

First QC Date

August 19, 2021

Last Update Submit

May 23, 2022

Conditions

Keywords

Thoracolumbar Interfascial Plane BlockErector Spinae Plane BlockThoracolumbar Decompressive Surgery

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery (QoR-40) Score

    QoR-40, a 40-item questionnaire that provides a global score and subscores across five dimensions: patient support, comfort, emotions, physical independence, and pain. I rate each item on a scale of 1-5, providing a minimum score of 40 and maximum of 200.QoR-40, a 40-item questionnaire that provides a global score and sub-scores across five dimensions: patient support, comfort, emotions, physical independence, and pain. Each item is rated on a scale of 1-5, providing a minimum score of 40 and maximum of 200.Global QoR-40 scores range from 40 to 200 representing, respectively, very poor to outstanding quality of recovery. QoR-40 score will be recorded on the morning of operation and at the postoperative 24th hour.

    Postoperative 24th hour

Secondary Outcomes (6)

  • Area under the Numeric Rating Scale pain score versus time

    Postoperative 24 hours

  • Numeric Rating Scale pain score

    Postoperative 24 hours

  • Documentation of adverse events

    Postoperative 24 hours

  • Postoperative opioid consumption in the first 24 hours

    Postoperative 24 hours

  • Time for administration of first opioid analgesia

    Postoperative 24 hours

  • +1 more secondary outcomes

Study Arms (2)

Group TLIP

ACTIVE COMPARATOR

Patients will receive a Thoracolumbar Plane Block (TLIPB) under ultrasound guidance while under general anesthesia. Intervention: Patients will receive a TLIPB with 20mls 0.25% Bupivicaine bilaterally.

Procedure: TLIPB

Group ESP

EXPERIMENTAL

Patients will receive an Erector Spinae Plane Block (ESPB) under ultrasound guidance while under general anesthesia. Intervention: Procedure: Patients will receive an ESPB with 20 ml 0.25% Bupivacaine bilaterally.

Procedure: ESPB

Interventions

TLIPBPROCEDURE

Patients will receive TLIPB with an injection of 40 ml of bupivacaine 0.25% (2 injections of 20 ml on each side) between multifidus and longissimus muscles.

Also known as: Global Quality of Recovery-40 score, Standard Pain Follow up and Monitorization
Group TLIP
ESPBPROCEDURE

Patients will receive ESPB with an injection of 40 ml of bupivacaine 0.25% (2 injections of 20 ml on each side) between erector spinae muscle and transverse process of a vertebra.

Also known as: Global Quality of Recovery-40 score, Standard Pain Followup and Monitorization
Group ESP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 18 years old,
  • Undergoing posterior lumbar spinal one to three levels fusion surgery
  • Having signed a written informed consent form,
  • ASAI-III

You may not qualify if:

  • Contraindication for regional anesthesia (allergy to local anesthetics, neuropathic disease, infection at the puncture site, coagulation disorder, refusal of the technique,…)
  • Contraindication to nonsteroidal anti-inflammatory drugs,
  • Patient who has already had a spinal surgery,
  • Patient with chronic pain syndrome (use \> 3 months of morphine, opioid analgesics of class 3, pregabalin or gabapentin) or fibromyalgia,
  • A mental or linguistic inability to understand the study,
  • Pregnant or or breastfeeding women,
  • Patient who can not communicate in Turkish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karaman Training and Research Hospital

Karaman, 70200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Betul Basaran, MD, DESA

    Karaman Training and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Blocks will be administered after induction of General Anesthesia so participants will be blinded to which intervention they have had. Study investigators will not be aware of what group the participant belongs to when assessing the patient's post-operative period
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized control trial one group receives Thoracolumbar Interfascial Plane Block the other receives Erector Spinae Plane Block
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2021

First Posted

August 27, 2021

Study Start

September 10, 2021

Primary Completion

May 23, 2022

Study Completion

May 23, 2022

Last Updated

May 24, 2022

Record last verified: 2021-09

Locations